Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel strategies to assess cytokine release mediated by chimeric antigen receptor T cells based on the adverse outcome pathway concept.
Alb M, Reiche K, Rade M, Sewald K, Loskill P, Cipriano M, Maulana TI, van der Meer AD, Weener HJ, Clerbaux LA, Fogal B, Patel N, Adkins K, Lund E, Perkins E, Cooper C, van den Brulle J, Morgan H, Rubic-Schneider T, Ling H, DiPetrillo K, Moggs J, Köhl U, Hudecek M. Alb M, et al. J Immunotoxicol. 2024 Oct;21(sup1):S13-S28. doi: 10.1080/1547691X.2024.2345158. Epub 2024 Dec 10. J Immunotoxicol. 2024. PMID: 39655500 Free article. Review.
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways.
Mazein A, Shoaib M, Alb M, Sakellariou C, Sommer C, Sewald K, Reiche K, Gogesch P, Roser LA, Ortega Iannazzo S, Sheth S, Schiffmann S, Waibler Z, Neuhaus V, Dehmel S, Satagopam V, Schneider R, Ostaszewski M, Gu W. Mazein A, et al. Among authors: alb m. J Immunotoxicol. 2024 Oct;21(sup1):S5-S12. doi: 10.1080/1547691X.2024.2345154. Epub 2024 Dec 10. J Immunotoxicol. 2024. PMID: 39655493 Free article.
Cellular Therapies for Multiple Myeloma: Engineering Hope.
Vera-Cruz S, Jornet Culubret M, Konetzki V, Alb M, Friedel SR, Hudecek M, Einsele H, Danhof S, Scheller L. Vera-Cruz S, et al. Among authors: alb m. Cancers (Basel). 2024 Nov 19;16(22):3867. doi: 10.3390/cancers16223867. Cancers (Basel). 2024. PMID: 39594822 Free PMC article. Review.
Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells.
Maulana TI, Teufel C, Cipriano M, Roosz J, Lazarevski L, van den Hil FE, Scheller L, Orlova V, Koch A, Hudecek M, Alb M, Loskill P. Maulana TI, et al. Among authors: alb m. Cell Stem Cell. 2024 Jul 5;31(7):989-1002.e9. doi: 10.1016/j.stem.2024.04.018. Epub 2024 May 15. Cell Stem Cell. 2024. PMID: 38754430 Free article.
Restoration of the ER stress response protein TDAG51 in hepatocytes mitigates NAFLD in mice.
Yousof TR, Bouchard CC, Alb M, Lynn EG, Lhoták S, Jiang H, MacDonald M, Li H, Byun JH, Makda Y, Athanasopoulos M, Maclean KN, Cherrington NJ, Naqvi A, Igdoura SA, Krepinsky JC, Steinberg GR, Austin RC. Yousof TR, et al. Among authors: alb m. J Biol Chem. 2024 Feb;300(2):105655. doi: 10.1016/j.jbc.2024.105655. Epub 2024 Jan 16. J Biol Chem. 2024. PMID: 38237682 Free PMC article.
Teclistamab impairs detection of BCMA CAR-T cells.
Glatte B, Wenk K, Grahnert A, Friedrich M, Merz M, Vucinic V, Fischer L, Reiche K, Alb M, Hudecek M, Franz P, Fricke S, Platzbecker U, Koehl U, Sack U, Boldt A, Hauschildt S, Weiss R. Glatte B, et al. Among authors: alb m. Blood Adv. 2023 Aug 8;7(15):3842-3845. doi: 10.1182/bloodadvances.2023009714. Blood Adv. 2023. PMID: 37026812 Free PMC article. No abstract available.
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models.
Donnadieu E, Luu M, Alb M, Anliker B, Arcangeli S, Bonini C, De Angelis B, Choudhary R, Espie D, Galy A, Holland C, Ivics Z, Kantari-Mimoun C, Kersten MJ, Köhl U, Kuhn C, Laugel B, Locatelli F, Marchiq I, Markman J, Moresco MA, Morris E, Negre H, Quintarelli C, Rade M, Reiche K, Renner M, Ruggiero E, Sanges C, Stauss H, Themeli M, Van den Brulle J, Hudecek M, Casucci M. Donnadieu E, et al. Among authors: alb m. J Immunother Cancer. 2022 May;10(5):e003486. doi: 10.1136/jitc-2021-003486. J Immunother Cancer. 2022. PMID: 35577500 Free PMC article. Review.
Impact of Prior Antiplatelet Therapy on Outcomes After Endovascular Therapy for Acute Stroke: Endovascular Treatment in Ischemic Stroke Registry Results.
Couture M, Finitsis S, Marnat G, Richard S, Bourcier R, Constant-Dits-Beaufils P, Dargazanli C, Arquizan C, Mazighi M, Blanc R, Eugène F, Vannier S, Spelle L, Denier C, Touzé E, Barbier C, Saleme S, Macian F, Rosso C, Clarençon F, Naggara O, Turc G, Ozkul-Wermester O, Papagiannaki C, Viguier A, Cognard C, Lebras A, Evain S, Wolff V, Pop R, Timsit S, Gentric JC, Bourdain F, Veunac L, Lapergue B, Consoli A, Gory B, Sibon I; ETIS Registry Investigators*. Couture M, et al. Stroke. 2021 Dec;52(12):3864-3872. doi: 10.1161/STROKEAHA.121.034670. Epub 2021 Sep 20. Stroke. 2021. PMID: 34538083
26 results